Jury Hits Takeda With $2M In Damages In Philly Actos Case

Law360, Philadelphia (October 3, 2014, 6:08 PM EDT) -- A Philadelphia jury slapped Takeda Pharmaceutical Co. Ltd. with over $2 million in damages Friday afternoon after finding that the diabetes drug Actos had contributed to a plaintiff’s bladder cancer and that the company had failed to adequately warn physicians about the risks associated with the medication.

After five hours of deliberation, eight out of nine jurors agreed to award plaintiff Frances Wisniewski $2,050,000 as part of a verdict finding that Takeda negligently failed to include adequate information about the potential links to bladder cancer on...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.